致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Human CXCL4L1, hFc-tag
目录号 NBL-241813
别名 CXCL4L1
外观 see COA
分子量 Phe31-Ser104
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 P10720
备注2
目录号 规格 价格 库存状态  
NBL-241813-100ug 100ug Inquire Inquire
NBL-241813-1mg 1mg Inquire Inquire
NBL-241813-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human CXCL4L1, hFc-tag


Catalog#:

NBL-241813


Description:

NebuSelect™ Recombinant Human CXCL4L1, hFc-tag(Cat#NBL-241813) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Phe31-Ser104.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 35.01 kDa. Due to glycosylation, the protein migrates to 43-48 kDa based on Bis-Tris PAGE result.


Target Name:

CXCL4L1


Target Information:

Platelet factor-4 (CXCL4/PF-4) was the first chemokine shown to inhibit angiogenesis. CXCL4L1/PF-4var, recently isolated from thrombin-stimulated platelets, differing from authentic CXCL4/PF-4 in three carboxy-terminally located amino acids, was found to be more potent than CXCL4/PF-4 in inhibiting angiogenesis and tumor growth. Both glycosaminoglycans (GAG) and CXCR3 are implicated in the activities of the PF-4 variants.


Amino Acid Sequence: 

Phe31-Ser104


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品